Press

November 30, 2017

Landmark asthma study demonstrates device choice determines asthma control

A landmark real-world study of more than 18,000 patients has demonstrated superior asthma control with the AeroChamber Plus* Flow-Vu* antistatic Valved Holding Chamber (VHC, or spacer) compared with other chamber devices.1 For those with asthma, particularly children, the choice of device to deliver their medication is an important considerat

July 6, 2017

Trudell Medical International: Providing patient-focused solutions and reducing health system costs: Our journey in the global fight against COPD

Chronic Obstructive Pulmonary Disease (COPD) is a significant healthcare problem, with an estimated 384 million cases worldwide in 2010.Population aging is predicted to drive further growth, with one study forecasting a 150% increase in prevalence overall, and up to 220% in the 75 and over age group, between 2010 and 2030.2